4/23
08:39 am
atrc
AtriCure upgraded at Oppenheimer on valuation [Seeking Alpha]
Low
Report
AtriCure upgraded at Oppenheimer on valuation [Seeking Alpha]
4/23
07:01 am
atrc
AtriCure, Inc. (NASDAQ: ATRC) was upgraded by analysts at Oppenheimer Holdings Inc. from a "market perform" rating to an "outperform" rating. They now have a $32.00 price target on the stock.
Low
Report
AtriCure, Inc. (NASDAQ: ATRC) was upgraded by analysts at Oppenheimer Holdings Inc. from a "market perform" rating to an "outperform" rating. They now have a $32.00 price target on the stock.
4/19
11:01 am
atrc
AtriCure's (ATRC) cryoSPHERE+ Probe to Aid in Pain Management [Yahoo! Finance]
Low
Report
AtriCure's (ATRC) cryoSPHERE+ Probe to Aid in Pain Management [Yahoo! Finance]
4/18
08:04 am
atrc
AtriCure Announces Launch of the cryoSPHERE®+ Probe for Post-Operative Pain Management [Yahoo! Finance]
Low
Report
AtriCure Announces Launch of the cryoSPHERE®+ Probe for Post-Operative Pain Management [Yahoo! Finance]
4/18
08:00 am
atrc
AtriCure Announces Launch of the cryoSPHERE®+ Probe for Post-Operative Pain Management
Low
Report
AtriCure Announces Launch of the cryoSPHERE®+ Probe for Post-Operative Pain Management
4/10
08:06 am
atrc
AtriCure, Inc. (NASDAQ: ATRC) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $46.00 price target on the stock.
Medium
Report
AtriCure, Inc. (NASDAQ: ATRC) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $46.00 price target on the stock.
4/10
08:00 am
atrc
AtriCure to Announce First Quarter 2024 Financial Results
Medium
Report
AtriCure to Announce First Quarter 2024 Financial Results
3/27
02:06 am
atrc
AtriCure, Inc. (NASDAQ: ATRC) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Medium
Report
AtriCure, Inc. (NASDAQ: ATRC) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
3/26
08:25 am
atrc
AtriCure to Participate in the 23rd Annual Needham Virtual Healthcare Conference [Yahoo! Finance]
Low
Report
AtriCure to Participate in the 23rd Annual Needham Virtual Healthcare Conference [Yahoo! Finance]
3/26
08:00 am
atrc
AtriCure to Participate in the 23rd Annual Needham Virtual Healthcare Conference
Medium
Report
AtriCure to Participate in the 23rd Annual Needham Virtual Healthcare Conference
3/25
02:06 am
atrc
Tricares Announces the Appointment of Ahmed Elmouelhi as President & Chief Executive Officer [Yahoo! Finance]
Low
Report
Tricares Announces the Appointment of Ahmed Elmouelhi as President & Chief Executive Officer [Yahoo! Finance]
3/22
06:48 am
atrc
AtriCure (ATRC) Declined due to Concerns Over Anti-Obesity Drug [Yahoo! Finance]
Medium
Report
AtriCure (ATRC) Declined due to Concerns Over Anti-Obesity Drug [Yahoo! Finance]
3/19
11:11 pm
atrc
AtriCure, Inc. (NASDAQ: ATRC) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Medium
Report
AtriCure, Inc. (NASDAQ: ATRC) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
3/7
09:16 am
atrc
Chief Legal Officer Karl Dahlquist Sells 8,231 Shares of AtriCure Inc (ATRC) [Yahoo! Finance]
Medium
Report
Chief Legal Officer Karl Dahlquist Sells 8,231 Shares of AtriCure Inc (ATRC) [Yahoo! Finance]
2/28
01:11 am
atrc
AtriCure (ATRC) Fell on Competitor Action [Yahoo! Finance]
Low
Report
AtriCure (ATRC) Fell on Competitor Action [Yahoo! Finance]
2/19
11:04 pm
atrc
AtriCure, Inc. (NASDAQ: ATRC) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Low
Report
AtriCure, Inc. (NASDAQ: ATRC) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
2/16
01:35 pm
atrc
AtriCure, Inc. (NASDAQ: ATRC) had its price target raised by analysts at UBS Group AG from $57.00 to $58.00. They now have a "buy" rating on the stock.
Low
Report
AtriCure, Inc. (NASDAQ: ATRC) had its price target raised by analysts at UBS Group AG from $57.00 to $58.00. They now have a "buy" rating on the stock.
2/16
11:41 am
atrc
AtriCure, Inc. (NASDAQ:ATRC) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Low
Report
AtriCure, Inc. (NASDAQ:ATRC) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
2/16
10:44 am
atrc
AtriCure, Inc. (NASDAQ: ATRC) had its price target lowered by analysts at Stifel Nicolaus from $50.00 to $42.00. They now have a "buy" rating on the stock.
Low
Report
AtriCure, Inc. (NASDAQ: ATRC) had its price target lowered by analysts at Stifel Nicolaus from $50.00 to $42.00. They now have a "buy" rating on the stock.
2/16
08:11 am
atrc
AtriCure, Inc. (NASDAQ: ATRC) had its price target raised by analysts at Needham & Company LLC from $44.00 to $46.00. They now have a "buy" rating on the stock.
Medium
Report
AtriCure, Inc. (NASDAQ: ATRC) had its price target raised by analysts at Needham & Company LLC from $44.00 to $46.00. They now have a "buy" rating on the stock.
2/15
08:55 pm
atrc
Here's What Key Metrics Tell Us About AtriCure (ATRC) Q4 Earnings [Yahoo! Finance]
Medium
Report
Here's What Key Metrics Tell Us About AtriCure (ATRC) Q4 Earnings [Yahoo! Finance]
2/15
07:02 pm
atrc
AtriCure (ATRC) Reports Q4 Loss, Tops Revenue Estimates [Yahoo! Finance]
Medium
Report
AtriCure (ATRC) Reports Q4 Loss, Tops Revenue Estimates [Yahoo! Finance]
2/15
04:55 pm
atrc
AtriCure Inc (ATRC) Reports Strong Revenue Growth in Q4 and Full Year 2023 [Yahoo! Finance]
Medium
Report
AtriCure Inc (ATRC) Reports Strong Revenue Growth in Q4 and Full Year 2023 [Yahoo! Finance]
2/15
04:14 pm
atrc
AtriCure Reports Fourth Quarter 2023 and Full Year 2023 Financial Results [Yahoo! Finance]
Medium
Report
AtriCure Reports Fourth Quarter 2023 and Full Year 2023 Financial Results [Yahoo! Finance]
2/15
04:01 pm
atrc
AtriCure Reports Fourth Quarter 2023 and Full Year 2023 Financial Results
Medium
Report
AtriCure Reports Fourth Quarter 2023 and Full Year 2023 Financial Results